期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
石杉碱甲对自身免疫性甲状腺炎小鼠的保护作用
1
作者 李智奇 王佑权 代微 《山西医科大学学报》 2025年第1期36-42,共7页
目的 探讨石杉碱甲对自身免疫性甲状腺炎小鼠的保护作用及其机制。方法 40只雌性C57BL/6小鼠随机分为空白对照组、模型组、石杉碱甲低剂量组和石杉碱甲高剂量组,每组10只。除空白对照组外,其他组小鼠采用皮下多点注射猪甲状腺球蛋白联... 目的 探讨石杉碱甲对自身免疫性甲状腺炎小鼠的保护作用及其机制。方法 40只雌性C57BL/6小鼠随机分为空白对照组、模型组、石杉碱甲低剂量组和石杉碱甲高剂量组,每组10只。除空白对照组外,其他组小鼠采用皮下多点注射猪甲状腺球蛋白联合高碘水的方法构建自身免疫性甲状腺炎模型。造模后,石杉碱甲低剂量组和高剂量组分别以0.05 mg/(kg·d)和0.2 mg/(kg·d)腹腔注射石杉碱甲注射液4周,空白对照组和模型组小鼠腹腔注射等量生理盐水。取材后检测各组小鼠血清甲状腺球蛋白抗体(TGAb)、甲状腺过氧化物酶抗体(TPOAb)、促甲状腺激素(TSH)、干扰素γ(IFN-γ)、肿瘤坏死因子α(TNF-α)和白介素10(IL-10)的水平;HE染色法观察甲状腺组织病理学变化;Western blot法和免疫组化法检测甲状腺组织Toll样受体4(TLR4)、核因子-κB p65(NF-κB p65)、磷酸化NF-κB p65(p-NF-κB p65)和黑素瘤缺乏因子2(AIM2)蛋白的表达水平。结果与空白对照组比较,模型组血清TGAb、TPOAb、IFN-γ、TSH和TNF-α水平明显升高(P<0.01),而IL-10水平明显降低(P<0.001),甲状腺组织中可见大量炎症细胞浸润,甲状腺组织中TLR4、p-NF-κB p65和AIM2蛋白表达水平明显上调(P<0.001)。与模型组比较,石杉碱甲低剂量组和高剂量组血清TGAb、TPOAb、IFN-γ、TSH和TNF-α水平显著降低(P<0.01),IL-10水平升高(P<0.01),甲状腺组织炎症细胞浸润减少,甲状腺组织TLR4、p-NF-κB p65和AIM2蛋白的表达水平下调(P<0.01)。与石杉碱甲低剂量组比较,石杉碱甲高剂量组血清TGAb、TPOAb、IFN-γ、TSH和TNF-α水平显著降低(P<0.01),IL-10水平升高(P<0.01),甲状腺组织炎症细胞浸润减少,甲状腺组织中TLR4、p-NF-κB p65和AIM2蛋白的表达水平下调(P<0.05)。结论 石杉碱甲通过调控TLR4/NF-κB/AIM2信号通路抑制炎症,从而改善自身免疫性甲状腺炎。 展开更多
关键词 石杉碱甲 自身免疫性甲状腺炎 小鼠 TLR4/NF-κB/AIM2信号通路 炎症 桥本氏甲状腺炎
暂未订购
桥本甲状腺炎免疫治疗的研究进展 被引量:25
2
作者 刘晓云 段宇 刘超 《医学综述》 2006年第6期344-346,共3页
桥本甲状腺炎是临床常见的自身免疫性甲状腺疾病,其处理仍以激素替代为主流,不能从病因的角度加以治疗,同时患者往往需要反复调药,负担较重。近年来出现了各种从免疫调节的角度来治疗本病的新方法,能够使患者的甲状腺自身抗体水平下降,... 桥本甲状腺炎是临床常见的自身免疫性甲状腺疾病,其处理仍以激素替代为主流,不能从病因的角度加以治疗,同时患者往往需要反复调药,负担较重。近年来出现了各种从免疫调节的角度来治疗本病的新方法,能够使患者的甲状腺自身抗体水平下降,肿大的甲状腺得到缩小,患者的自觉症状得到改善等。其中,针对各种生物和基因治疗、局部免疫调节或祖国传统中医中药等的研究资料表明治疗效果显著。 展开更多
关键词 桥本甲状腺炎 免疫治疗 自身免疫性甲状腺炎 实验性自身免疫性甲状腺炎
暂未订购
Reactive lymphoid hyperplasia of the liver:A case report and review of literature 被引量:13
3
作者 Takuro Machida Toshiyuki Takahashi +3 位作者 Tomoo Itoh Michiaki Hirayama Takayuki Morita Shoichi Horita 《World Journal of Gastroenterology》 SCIE CAS CSCD 2007年第40期5403-5407,共5页
A case of a 53-year-old female patient with reactive lymphoid hyperplasia (RLH), clinically designated as pseudolymphoma of the liver is described in this article. The patient was admitted to our hospital for furthe... A case of a 53-year-old female patient with reactive lymphoid hyperplasia (RLH), clinically designated as pseudolymphoma of the liver is described in this article. The patient was admitted to our hospital for further evaluation of hepatic tumors incidentally discovered at another hospital. Various diagnostic methods, including ultrasonography (US), computerized tomography (CT), magnetic resonance imaging (MRI) and hepatic angiography displayed three small lesions in the liver with outstanding findings consistent with hepatocellular carcinoma (HCC). Surgical resection was performed and the three lesions were microscopically diagnosed as RLH of the liver. The lesions comprised a massive infiltration of lymphoid cells with follicles and hyalinized inter- follicular spaces. Immunohistochemical examination revealed that infiltrating lymphocytes had no prominent nuclear atypia and polyclonality. RLH of the liver is a very rare condition and only twelve cases have been reported in the English literature. Majority of the reported cases were middle-aged women and about half of them had some immunologic abnormalities such as autoimmune thyroiditis, Sjogren's syndrome, primary immunodeficiency, primary biliary cirrhosis. Since they are olden clinically misdiagnosed as HCC, surgery is the choice of treatment for these patients. Although their pathology resembles malignant lymphoma, the clinical course is completely benign. The authors propose that RLH of the liver can be discriminated from HCC by its clinical features. 展开更多
关键词 Reactive lymphoid hyperplasia Pseudo lymphoma Hepatocellular carcinoma autoimmunethyroiditis IMMUNOHISTOCHEMISTRY
暂未订购
Gastrointestinal manifestations of endocrine disease 被引量:1
4
作者 Christina Maser Arnbjorn Toset Sanziana Roman 《World Journal of Gastroenterology》 SCIE CAS CSCD 2006年第20期3174-3179,共6页
The hormonal interactions among the systems throughout the body are not fully understood; many vague clinical symptoms may in fact be manifestations of underlying endocrine diseases. The aim of the following review is... The hormonal interactions among the systems throughout the body are not fully understood; many vague clinical symptoms may in fact be manifestations of underlying endocrine diseases. The aim of the following review is to discuss gastrointestinal manifestations of surgically correctable endocrine diseases, focusing on abnormalities of thyroid function, cancer and finally autoimmune diseases. We also review manifestations of pancreatic endocrine tumors, and multiple endocrine neoplasia. 展开更多
关键词 Functional thyroid disease autoimmunethyroid disease Thyroid malignancy Islet cell tumors
暂未订购
上一页 1 下一页 到第
使用帮助 返回顶部